ASX:APIAustralian Pharmaceutical Industries Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Australian Pharmaceutical Industries Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add Add Compare Share Today's Range N/A50-Day RangeA$1.09MA: A$1.09▼A$1.0952-Week Range N/AVolume453,647 shsAverage Volume1.60 million shsMarket Capitalization$537.00 millionP/E Ratio10.28Dividend Yield7.58%BetaN/A ProfileAdvanced ChartCompetitorsDividendEarningsInsider TradesHeadlines Australian Pharmaceutical Industries Limited engages in the wholesale distribution of pharmaceutical, medical, health, beauty, and lifestyle products to pharmacies primarily in Australia. The company also retails health and beauty products to consumers; and manufactures and distributes pharmaceutical and toiletry goods to New Zealand, Australian, and Asian markets, as well as provides cosmetic products and procedures. In addition, its services include wholesale product delivery, retail services, marketing programs, and business advisory services. The company markets its products and services under the Soul Pattinson Chemist, Pharmacist Advice, Club Premium, and Pharmacy Best Buys brand names, as well as through 475 Priceline and Priceline Pharmacy franchise stores, and company owned Priceline stores. Australian Pharmaceutical Industries Limited was founded in 1910 and is based in Camberwell, Australia.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Australian Pharmaceutical Industries. Previous Next 2.4 Community Rank Outperform VotesAustralian Pharmaceutical Industries has received 44 “outperform” votes. (Add your “outperform” vote.)Underperform VotesAustralian Pharmaceutical Industries has received 49 “underperform” votes. (Add your “underperform” vote.)Community SentimentAustralian Pharmaceutical Industries has received 52.69% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Australian Pharmaceutical Industries and other stocks. Vote “Outperform” if you believe API will outperform the S&P 500 over the long term. Vote “Underperform” if you believe API will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 1.7 Dividend Strength Dividend LeadershipAustralian Pharmaceutical Industries is a leading dividend payer. It pays a dividend yield of 7.58%, putting its dividend yield in the top 25% of dividend-paying stocks.Dividend GrowthAustralian Pharmaceutical Industries does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Australian Pharmaceutical Industries is 75.47%. Payout ratios above 75% are not desirable because they may not be sustainable. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Australian Pharmaceutical Industries insiders have not sold or bought any company stock. Previous Next 1.3 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Australian Pharmaceutical Industries is 10.28, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 15.71.Price to Earnings Ratio vs. SectorThe P/E ratio of Australian Pharmaceutical Industries is 10.28, which means that it is trading at a less expensive P/E ratio than the Services sector average P/E ratio of about 30.47. Previous Next Analyst Opinion: 0.0Community Rank: 2.4Dividend Strength: 1.7Insider Behavior: 0.0Valuation: 1.3 5 -4 -3 -2 -1 -Overall Beat the Market Rank™1.06 out of 5 stars Industry, Sector and Symbol Stock Exchange ASX Industry Medical Equipment Wholesale Sub-IndustryN/A SectorServices Current SymbolASX:API Previous Symbol CUSIPN/A CIKN/A Webwww.api.net.au Phone+61-3-88553000Debt Debt-to-Equity Ratio67.79 Current Ratio1.26 Quick Ratio0.75Price-To-Earnings Trailing P/E Ratio10.28 Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$4.07 billion Price / Sales0.00 Cash FlowN/A Price / Cash Flow8.26 Book ValueA$1.03 per share Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding Shares492,656,000Market Cap$537.00 million Next Earnings Date10/19/2020 (Estimated) OptionableNot Optionable Receive API News and Ratings via Email Sign-up to receive the latest news and ratings for API and its competitors with MarketBeat's FREE daily newsletter. Australian Pharmaceutical Industries (ASX:API) Frequently Asked Questions When is Australian Pharmaceutical Industries' next earnings date? Australian Pharmaceutical Industries is scheduled to release its next quarterly earnings announcement on Monday, October 19th 2020. View our earnings forecast for Australian Pharmaceutical Industries. How were Australian Pharmaceutical Industries' earnings last quarter? Australian Pharmaceutical Industries Ltd (ASX:API) posted its earnings results on Wednesday, April, 17th. The company reported $0.05 EPS for the quarter, missing analysts' consensus estimates of $0.05 by $0.00. View Australian Pharmaceutical Industries' earnings history. How often does Australian Pharmaceutical Industries pay dividends? What is the dividend yield for Australian Pharmaceutical Industries? Australian Pharmaceutical Industries declared a final dividend on Monday, October 28th. Stockholders of record on Thursday, December 12th will be paid a dividend of 0.04 per share on Thursday, December 12th. This represents a yield of 2.93%. The ex-dividend date is Wednesday, November 13th. View Australian Pharmaceutical Industries' dividend history. Has Australian Pharmaceutical Industries been receiving favorable news coverage? Media headlines about API stock have trended extremely negative on Sunday, according to InfoTrie Sentiment. InfoTrie identifies negative and positive press coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Australian Pharmaceutical Industries earned a daily sentiment score of -4.8 on InfoTrie's scale. They also gave headlines about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the stock's share price in the next several days. View the latest news about Australian Pharmaceutical Industries. Who are some of Australian Pharmaceutical Industries' key competitors? Some companies that are related to Australian Pharmaceutical Industries include Navitas (NVT), GlobalData (DATA), Hays (HAS), Royal Mail (RMG), Serco Group (SRP), Keywords Studios (KWS), Fairfax Media (FXJ), Bapcor (BAP), InvoCare (IVC), Greggs (GRG), Future (FUTR), PROSPECT CAPITAL 6.25 NTS (PBY), Super Retail Group (SUL), Dart Group (DTG) and SSP Group (SSPG). View all competitors. What other stocks do shareholders of Australian Pharmaceutical Industries own? Based on aggregate information from My MarketBeat watchlists, some companies that other Australian Pharmaceutical Industries investors own include Capricorn Metals (CMM), Austal (ASB), Mod Resources (MOD), Harvey Norman (HVN), Evolution Mining (EVN) and Downer EDI (DOW). Who are Australian Pharmaceutical Industries' key executives? Australian Pharmaceutical Industries' management team includes the following people: Mr. Richard C. Vincent B.Bus, (Accountancy), CPA, MD, CEO & Exec. DirectorMr. Peter Mendo, Chief Financial OfficerMr. Dean Matthews, Chief Information OfficerMr. Peter F. Sanguinetti, Gen. Counsel & Company Sec. (Age 63)Mr. Stephen Arthurson, Gen. Mang. of People What is Australian Pharmaceutical Industries' stock symbol? Australian Pharmaceutical Industries trades on the ASX under the ticker symbol "API." How big of a company is Australian Pharmaceutical Industries? Australian Pharmaceutical Industries has a market capitalization of $0.00 and generates $4.07 billion in revenue each year. What is Australian Pharmaceutical Industries' official website? The official website for Australian Pharmaceutical Industries is www.api.net.au. How can I contact Australian Pharmaceutical Industries? Australian Pharmaceutical Industries' mailing address is L 5 250 Camberwell Rd, MELBOURNE, VIC 3124, Australia. The company can be reached via phone at +61-3-88553000. This page was last updated on 8/9/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
